dc.contributor.author | Karakişi, Sedat Ozan | |
dc.contributor.author | Ergene, Şaban | |
dc.contributor.author | Hemşinli, Doğuş | |
dc.date.accessioned | 2020-12-19T20:42:50Z | |
dc.date.available | 2020-12-19T20:42:50Z | |
dc.date.issued | 2019 | |
dc.identifier.issn | 2667-4947 | |
dc.identifier.issn | 2667-5080 | |
dc.identifier.uri | https://doi.org/10.9739/tjvs.2019.331 | |
dc.identifier.uri | https://app.trdizin.gov.tr/makale/TXpZMk16QXpNdz09 | |
dc.identifier.uri | https://hdl.handle.net/11436/5784 | |
dc.description.abstract | Objectives: This study aims to present early and mid-term results of thoracic endovascular aortic repair. Patients and methods: A total of 24 male patients (mean age 63.5 years; range, 31 to 80 years) who underwent endovascular aortic repair in our clinic due to a descending thoracic aortic aneurysm or acute aortic syndrome between December 2011 and January 2017 were retrospectively analyzed. Data including demographic characteristics, pre-procedural additional diagnoses, mortality and morbidity data, length of intensive care unit and hospital stays, amount of blood products used, and complications were recorded. Results: The mean follow-up was 42.7 (range, 22 to 60) months, the mean length of intensive care unit stay was one (range, 1 to 3) day, and the mean length of hospital stay was 5.5 (range, 4 to 30) days. The mean amount of erythrocyte suspension applied during the procedure was 0.4 (range, 0 to 3) Unit. Post-procedural acute kidney failure developed in two and transient paraplegia in three patients. Endoleak was detected in three patients during follow-up. Peri-procedural mortality occurred in one patient. The operative mortality rate (mortality within the first 30 days) was 8% and the total mortality rate was 17%. Conclusion: The advantages of endovascular aortic repair include short intensive care and hospital stays, low blood product use, the ability to perform regional anesthesia in high-risk comorbid patients, and a low operative mortality rate. Our study results suggest that thoracic endovascular aortic repair is a promising and valid therapeutic technique with reduced complications rates, particularly for patients with comorbidities. | en_US |
dc.language.iso | eng | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Our early and mid-term results in thoracic aorta pathologies undergoing endovascular repair | en_US |
dc.type | article | en_US |
dc.contributor.department | RTEÜ | en_US |
dc.identifier.doi | 10.9739/tjvs.2019.331 | |
dc.identifier.volume | 28 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.startpage | 78 | en_US |
dc.identifier.endpage | 83 | en_US |
dc.ri.edit | oa | en_US |
dc.relation.journal | Turkish journal of vascular surgery | en_US |
dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Eleman | en_US |